Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. FLEX NATION Message Board

$IMMD **SOLID 15 MO GROWTH PLAN** Immudyne Anno

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 18867
Posted On: 04/29/2013 1:37:47 PM
Avatar
Posted By: The Pit Bull

$IMMD **SOLID 15 MO GROWTH PLAN**



Immudyne Announces 15-Month Plan for Growth and April 25th Conference Call



NEW YORK, April 18, 2013 (GLOBE NEWSWIRE) -- Immudyne, Inc. ( IMMD ) announced today that the company plans to execute a 15-Month Sales and Marketing Plan to accomplish increased revenue growth. The company will hold a conference call on Thursday, April 25th at 11 a.m. EDT. To participate in the call, please dial 1-800-816-4164. When prompted, enter the GUEST CODE of 636174#


Afterwards, a recording of the call will be available for listening by visiting immudyne.com/IR.


The company also released today a new corporate presentation outlining management's vision. The presentation can be found at http://www.immudyne.com/pages/investors-1


Highlights of the plan include rebranding the company with a new strategic focus, introducing new product lines, and expanding into new multi-billion dollar US markets.


Karen Kingston, Chief Marketing Officer, stated, "There are many internal and external factors that weaken our immune system, some of which are lifestyle decisions. Our product helps support the immune system even when consumers engage in lifestyle choices that suppress their innate immune response. Our product is a dietary supplement supported by excellent clinical data and consumer experience that has the potential to benefit millions of people within the United States immediately. We have developed a strategic marketing plan that we believe we can execute cost-effectively in order spread our message to millions of target customers."


Mark McLaughlin, President & CEO, stated, "We believe Immudyne's new strategic focus will result in accelerated revenue growth for the company. We plan to launch new product lines in several multi-billion dollar US markets that we have not targeted before. We also plan to expand our board of directors over the next year to strengthen our expert knowledge and create new strategic alliances."


About Immudyne


Immudyne is a health and wellness lifestyle company. Immudyne has a portfolio of unique patent-protected products with applications in the wellness lifestyle, skin care, anti-aging, fitness, and health markets. Immudyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, Kentucky.


Immudyne shares trade under the ticker symbol IMMD and the Company can be found on the web at  www.immudyne.com .


Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.


http://finance.yahoo.com/news/immudyne-announ...20943.html





(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us